Immunology Fall 2026: Lecture 22 T cell Trafficking
Overview
Dr. Brianne Barker explains how leukocytes exit blood vessels through a shared four-stage trafficking process: selectin-mediated rolling, chemokine activation, integrin-mediated firm arrest, and diapedesis. Using naive T-cell entry into lymph-node high endothelial venules (HEVs) and neutrophil recruitment to inflamed tissue as examples, she identifies key molecular pairs including L-selectin with HEV carbohydrate ligands, CCR7 with CCL19/CCL21, and LFA-1 with ICAM-1.
Key takeaways
- Leukocyte exit from blood is a four-stage process: selectin-mediated rolling, chemokine signaling, integrin-mediated arrest, and diapedesis.
- Selectin-carbohydrate interactions are deliberately weak and reversible, allowing rolling to slow a leukocyte without abruptly stopping it in fast blood flow.
- Naive lymphocytes use L-selectin and CCR7 to enter lymph-node HEVs, where carbohydrate ligands and CCL19/CCL21 provide matching trafficking cues.
- Chemokine-receptor signaling activates integrins; LFA-1 can then bind ICAM-1 strongly enough to stop a rolling T cell or neutrophil.
- Trafficking combinations act like a tissue-specific address code: cells express the appropriate selectins, chemokine receptors, and integrins for their destination.
- After HEV entry, naive T cells and dendritic cells converge in the lymph-node T-cell zone, enabling antigen presentation and the start of an adaptive immune response.
Chapters
- Naive T cells leave the thymus and reach lymph nodes through lymphatics or the bloodstream; this lecture focuses on blood-to-node entry.
- The same trafficking sequence guides neutrophils into inflamed tissue and activated T cells toward infected tissue.
- Fast, crowded blood flow makes an abrupt stop dangerous: a leukocyte could be sheared or obstruct circulation.
- The stages are rolling, activation, arrest or adhesion, and diapedesis, also called transendothelial migration.
- Rolling, activation, and arrest are studied in greater molecular detail than diapedesis, which is harder to isolate experimentally.
- The staged sequence slows cells before the strong adhesion needed to stop and exit the vessel.
- Leukocytes leave blood through veins rather than arteries; lymph-node veins specialize as high endothelial venules, or HEVs.
- HEVs have tall endothelial cells and provide an entry route for circulating lymphocytes into secondary lymphoid organs.
- The HEV is the blood-vessel site where naive T cells begin their entry into a lymph node.
- Selectins are lectins, meaning they bind carbohydrates; the major types are L-selectin (CD62L), P-selectin (CD62P), and E-selectin (CD62E).
- Weak, transient selectin-carbohydrate bonds repeatedly form and break, slowing leukocytes without abruptly stopping them.
- In a neutrophil example, endothelial P-selectin binds leukocyte PSGL-1 as blood flow pushes the cell along the vessel wall.
- Naive T and B cells display L-selectin, which binds carbohydrate ligands on HEVs, including CD34-associated ligands.
- Naive lymphocytes maintain L-selectin for lymph-node entry; after activation, they lose it as they redirect toward peripheral tissues.
- Neutrophils carry PSGL-1 constitutively, while inflamed endothelial tissue induces E-selectin or P-selectin to recruit them.
- Chemokines bind seven-transmembrane G protein-coupled receptors and trigger signaling that can reorganize actin and alter cell adhesion.
- Chemokine names such as CXCL1 and CCL2 identify ligands; receptor names use R, as in CXCR4.
- Different leukocyte types and activation states express different chemokine receptors, helping direct cells to the appropriate tissue.
- Naive lymphocytes express CCR7, which recognizes CCL19 and CCL21 produced continuously by HEVs.
- Activated T cells stop expressing CCR7 and use other chemokine-receptor pairs suited to their destination tissue.
- For neutrophil recruitment, IL-8 from inflamed tissue binds IL-8 receptors that neutrophils express while searching for inflammation.
- Integrins are alpha-beta heterodimers whose high-affinity binding to cell adhesion molecules (CAMs) can fully arrest a leukocyte.
- Chemokine-receptor signaling activates integrins by changing their conformation from a bent, low-affinity state to an extended, high-affinity state.
- Keeping integrins inactive until the correct chemokine signal prevents cells from stopping in the wrong place or obstructing blood flow.
- Naive T cells use LFA-1 to bind ICAM-1 on HEVs; neutrophils can also use LFA-1 to bind endothelial ICAM proteins.
- After firm arrest, cytoskeletal changes let the leukocyte spread and squeeze between endothelial cells without opening the vessel wall broadly.
- Diapedesis, transendothelial migration, and extravasation refer to this final passage into tissue; its mechanisms are less fully characterized.
- After entering through an HEV, a naive T cell follows cues into the lymph-node T-cell zone; B cells move toward a B-cell zone.
- Activated dendritic cells arrive through lymphatic vessels and also migrate to the T-cell zone to present antigen.
- Once antigen, dendritic cells, and naive lymphocytes meet in the secondary lymphoid organ, T-cell activation can begin.
Transcript excerpt
0:00 Hello. This is yet another lecture where I was having some technical difficulties um with my recording. So I'm recording this uh after the fact. Um so hopefully this is helpful. Um and today we're going to be talking about uh T cell trafficking. Um so really what we're thinking about with this problem of T cell trafficking is uh following our naive T cell that has um left the thymus and is getting ready to make a response. Um we're following that T cell into uh the lymph node. Um it's able to go there um through the lymphatic, which we're not going to say a ton about, um
0:49 or through the blood. Um and that's really where we're kind of focusing now is how that naive T cell is going to leave the bloodstream and enter the lymph node. As I've mentioned before, this same process um can happen for other types of immune cells leaving other leaving the blood cell the blood flow at other sites. Um we're just talking about it now since we're following the path of our naive T cell. Um and so here you can see some of those other situations that actually end up using the same process that we're going to be talking about today. So in the middle you can see our naive T cell or B cell that might come through um
1:36 the blood flow into the secondary lymphoid organ like a lymph node to start um immune responses. And that's why we're talking about this process here. But the exact same steps that we're going to be talking about today are steps that a neutrophil uses when it gets to an inflamed tissue and wants to leave the blood vessel and go that site of inflammation. Um, these are also the same set of steps
This is the start of the transcript. Save this video free for the whole transcript, searchable and time-coded.
In this course
Related notes
Summary, takeaways, and chapters were generated by AI from the video's transcript and may contain errors. The video belongs to its creator, Brianne Barker.